DAVID MCTAGUE: Open Payments
NPI 1740263144 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $102 |
| Novo Nordisk Inc | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| ABBVIE INC. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| MILLICENT US INC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: ELIQUIS, CAPLYTA, FARXIGA, QULIPTA, XIFAXAN, FEMRING, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
